VolitionRx Ltd (VNRX) stock
VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.19−0.01 (-5.56%)
Close on Nov 17, 2026Market cap $2.58MP/E –Yield –
VolitionRx total assets
Total assets on the balance sheet at the end of each period.
VolitionRx's total assets was $8.30M at Jun 30, 2026. For fiscal 2025 it was $6.90M, down 26.6% from the year before. Over ten years it grew -1.1% a year on average. The highest annual figure on record is $27.95M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.90M | -26.6% |
| FY2024 | Dec 31, 2024 | $9.40M | -66.4% |
| FY2023 | Dec 31, 2023 | $27.95M | +52.8% |
| FY2022 | Dec 31, 2022 | $18.30M | -33.4% |
| FY2021 | Dec 31, 2021 | $27.49M | +5.1% |
| FY2020 | Dec 31, 2020 | $26.15M | +22.8% |
| FY2019 | Dec 31, 2019 | $21.29M | +21.7% |
| FY2018 | Dec 31, 2018 | $17.49M | +19.6% |
| FY2017 | Dec 31, 2017 | $14.62M | -40.9% |
| FY2016 | Dec 31, 2016 | $24.73M | +220.7% |
| FY2015 | Dec 31, 2015 | $7.71M | +124.6% |
| FY2014 | Dec 31, 2014 | $3.43M | +65.8% |
| FY2013 | Dec 31, 2013 | $2.07M | -6.6% |
| FY2012 | Dec 31, 2012 | $2.22M | -1.3% |
| FY2011 | Dec 31, 2011 | $2.25M | +84.4% |
| FY2010 | Dec 31, 2010 | $1.22M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.30M | -4.6% |
| Q1 FY2026 | Mar 31, 2026 | $9.04M | +6.1% |
| Q4 FY2025 | Dec 31, 2025 | $6.90M | -26.6% |
| Q3 FY2025 | Sep 30, 2025 | $6.45M | -49.1% |
| Q2 FY2025 | Jun 30, 2025 | $8.70M | -33.4% |
| Q1 FY2025 | Mar 31, 2025 | $8.52M | -56.2% |
| Q4 FY2024 | Dec 31, 2024 | $9.40M | -66.4% |
| Q3 FY2024 | Sep 30, 2024 | $12.68M | -29.7% |
| Q2 FY2024 | Jun 30, 2024 | $13.07M | -52.6% |
| Q1 FY2024 | Mar 31, 2024 | $19.43M | +7.7% |
| Q4 FY2023 | Dec 31, 2023 | $27.95M | +52.8% |
| Q3 FY2023 | Sep 30, 2023 | $18.04M | -22.7% |
| Q2 FY2023 | Jun 30, 2023 | $27.56M | +13.2% |
| Q1 FY2023 | Mar 31, 2023 | $18.04M | -43.1% |
| Q4 FY2022 | Dec 31, 2022 | $18.30M | -33.4% |
| Q3 FY2022 | Sep 30, 2022 | $23.34M | -22.2% |
| Q2 FY2022 | Jun 30, 2022 | $24.35M | -30.9% |
| Q1 FY2022 | Mar 31, 2022 | $31.68M | -21.8% |
| Q4 FY2021 | Dec 31, 2021 | $27.49M | +5.1% |
| Q3 FY2021 | Sep 30, 2021 | $30.00M | +15.0% |
| Q2 FY2021 | Jun 30, 2021 | $35.24M | +34.3% |
| Q1 FY2021 | Mar 31, 2021 | $40.51M | +140.1% |
| Q4 FY2020 | Dec 31, 2020 | $26.15M | +22.8% |
| Q3 FY2020 | Sep 30, 2020 | $26.09M | +9.7% |
| Q2 FY2020 | Jun 30, 2020 | $26.25M | +14.7% |
| Q1 FY2020 | Mar 31, 2020 | $16.87M | -18.2% |
| Q4 FY2019 | Dec 31, 2019 | $21.29M | +21.7% |
| Q3 FY2019 | Sep 30, 2019 | $23.78M | +14.8% |
| Q2 FY2019 | Jun 30, 2019 | $22.88M | +40.4% |
| Q1 FY2019 | Mar 31, 2019 | $20.63M | +8.7% |
| Q4 FY2018 | Dec 31, 2018 | $17.49M | +19.6% |
| Q3 FY2018 | Sep 30, 2018 | $20.72M | +12.8% |
| Q2 FY2018 | Jun 30, 2018 | $16.30M | -22.3% |
| Q1 FY2018 | Mar 31, 2018 | $18.98M | -15.8% |
| Q4 FY2017 | Dec 31, 2017 | $14.62M | -40.9% |
| Q3 FY2017 | Sep 30, 2017 | $18.36M | +28.5% |
| Q2 FY2017 | Jun 30, 2017 | $20.97M | – |
| Q1 FY2017 | Mar 31, 2017 | $22.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $24.73M | – |
| Q3 FY2016 | Sep 30, 2016 | $14.29M | – |
See a number that looks wrong?